Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vita Coco Company (COCO) Common Equity (2020 - 2025)

Historic Common Equity for Vita Coco Company (COCO) over the last 6 years, with Q3 2025 value amounting to $323.7 million.

  • Vita Coco Company's Common Equity rose 2840.43% to $323.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $323.7 million, marking a year-over-year increase of 2840.43%. This contributed to the annual value of $258.8 million for FY2024, which is 2785.06% up from last year.
  • As of Q3 2025, Vita Coco Company's Common Equity stood at $323.7 million, which was up 2840.43% from $296.9 million recorded in Q2 2025.
  • In the past 5 years, Vita Coco Company's Common Equity registered a high of $323.7 million during Q3 2025, and its lowest value of $94.3 million during Q3 2021.
  • For the 5-year period, Vita Coco Company's Common Equity averaged around $195.9 million, with its median value being $192.6 million (2023).
  • As far as peak fluctuations go, Vita Coco Company's Common Equity soared by 985.18% in 2021, and later soared by 5020.95% in 2022.
  • Vita Coco Company's Common Equity (Quarter) stood at $123.2 million in 2021, then grew by 17.89% to $145.2 million in 2022, then surged by 39.41% to $202.4 million in 2023, then grew by 27.85% to $258.8 million in 2024, then increased by 25.08% to $323.7 million in 2025.
  • Its Common Equity stands at $323.7 million for Q3 2025, versus $296.9 million for Q2 2025 and $277.9 million for Q1 2025.